Rhythm Biosciences: Driving Innovation in Early Cancer Diagnosis

Rhythm Biosciences Ltd (ASX: RHY), based in Melbourne, is an Australian diagnostics company dedicated to creating accessible and cost-effective blood tests that enable earlier detection of cancer. The company recently completed full validation of its ColoSTAT® assay, a blood-based test for colorectal cancer. Clinical trials showed 91% sensitivity and a 98% negative predictive value, positioning ColoSTAT® as a safe and effective tool for triaging patients with bowel cancer symptoms and as an alternative to stool-based screening. Following successful validation using more than 450 analytical replicates and over 300 clinical samples, Rhythm has submitted data to the National Association of Testing Authorities (NATA) for inclusion of ColoSTAT® in its ISO15189 accreditation, paving the way for commercialisation. Supported by research from CSIRO and global patents, ColoSTAT® aims to reduce mortality and healthcare costs associated with colorectal cancer. Rhythm is also advancing its geneType™ risk assessment platform to expand into preventative healthcare and precision medicine.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com